fda category 2 bulk drug substances bpc-157 compounding list The Food and Administration's committee on compounded drugs broke with agency scientists and voted in favor of adding peptides to the of pharmacies can make. Follow the link Deep Dive: Regulatory Status of
Deep Dive: Regulatory Status of Popular Compounded Peptides Holt Law FDA Peptide Reclassification 2026: What It Means for Providers This just in: The FDA is proposing to move 14 commonly used peptides from Category 2 to Category 1 on the compounding review list If finalized, this shift could significantly change FDA's Overreach on Compounded Peptides BPC 157 just got voted in favor to be added to the 503A Bulk Drug Substances list, meaning a huge step towards being able to be prescribed and compounded in the US. Thank
Pay in 4 interest-free payments of $5.92 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12


